# PRR16

## Overview
PRR16 is a gene that encodes the proline-rich 16 protein, which is characterized by its abundance of proline residues. This protein is involved in various cellular processes, although its precise biological functions are not fully elucidated. The proline-rich 16 protein is implicated in cellular signaling pathways and may play a role in modulating cellular responses to environmental stimuli. Research has suggested that PRR16 is associated with cancer progression, particularly in liver hepatocellular carcinoma, where it is upregulated and linked to cancer stem cell characteristics (Bai2020Identification). Additionally, PRR16 has been identified as a gene with a high mutation rate in carotid paragangliomas, suggesting a potential role in tumorigenesis (Snezhkina2019Novel). Despite these associations, further studies are required to fully understand the functional implications of PRR16 and its encoded protein in health and disease.

## Clinical Significance
PRR16 has been implicated in various diseases and conditions through alterations in its expression and interactions. In liver hepatocellular carcinoma (LIHC), PRR16 is part of a gene module that is upregulated, suggesting its involvement in cancer stem cell characteristics and tumorigenesis. This upregulation is associated with pathways such as angiogenesis and autophagy, which are crucial for cancer progression (Bai2020Identification). The study by Bai et al. also highlights PRR16 as a potential therapeutic target to inhibit the stemness of cancer cells in LIHC (Bai2020Identification).

In the context of carotid paragangliomas (CPGLs), PRR16 was identified as one of the genes with a high mutation rate, indicating its potential role in tumorigenesis. However, the specific clinical significance of these mutations in CPGLs remains unclear (Snezhkina2019Novel).

Additionally, PRR16 was studied in relation to inflammatory bowel disease (IBD), where it was analyzed for genetic interactions with NOD2, a gene involved in immune response. Although PRR16 was identified as a candidate gene, its specific role in IBD pathogenesis was not confirmed (Thiébaut2016Characterization).

## Interactions



## References


[1. (Bai2020Identification) Kun‐Hao Bai, Si‐Yuan He, Ling‐Ling Shu, Wei‐Da Wang, Shi‐Yong Lin, Qian‐Yi Zhang, Liang Li, Lei Cheng, and Yu‐Jun Dai. Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by wgcna analysis of transcriptome stemness index. Cancer Medicine, 9(12):4290–4298, April 2020. URL: http://dx.doi.org/10.1002/cam4.3047, doi:10.1002/cam4.3047. This article has 79 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/cam4.3047)

[2. (Thiébaut2016Characterization) Raphaële Thiébaut, Sophie Esmiol, Patrick Lecine, Batoul Mahfouz, Aurelie Hermant, Cendrine Nicoletti, Stephane Parnis, Julie Perroy, Jean-Paul Borg, Leigh Pascoe, Jean-Pierre Hugot, and Vincent Ollendorff. Characterization and genetic analyses of new genes coding for nod2 interacting proteins. PLOS ONE, 11(11):e0165420, November 2016. URL: http://dx.doi.org/10.1371/journal.pone.0165420, doi:10.1371/journal.pone.0165420. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0165420)

[3. (Snezhkina2019Novel) A. V. Snezhkina, E. N. Lukyanova, M. S. Fedorova, D. V. Kalinin, N. V. Melnikova, O. A. Stepanov, M. V. Kiseleva, A. D. Kaprin, E. A. Pudova, and A. V. Kudryavtseva. Novel genes associated with the development of carotid paragangliomas. Molecular Biology, 53(4):547–559, July 2019. URL: http://dx.doi.org/10.1134/S0026893319040137, doi:10.1134/s0026893319040137. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1134/S0026893319040137)